CANY
TWST icon

Caxton Associates (New York)’s Twist Bioscience TWST Stock Holding History

Caxton Associates (New York)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,963
Closed -$590K – 653
2024
Q2 		$590K Buy
+11,963
New +$488K 0.02% 322

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Caxton Associates (New York)'s TWST Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 11,963 shares — an estimated $590K sold.

Caxton Associates (New York) first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $590K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 11,963 Twist Bioscience shares in Q3 2024, an estimated $590K.
  • Caxton Associates (New York) first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
  • Caxton Associates (New York)'s Twist Bioscience position peaked at $590K in Q2 2024.
  • 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.